Mutations in SMARCE1, BAP1, KLF4/TRAF7, TERT promoter, and CDKN2A/B deletion, H3K27me3 loss and methylation profiling are now officially associated with the classification and grading of meningiomas [7]. Here, CDKN2A is linked to meningioma.